Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Autoantibody Stories

2014-02-21 16:23:07

PHILADELPHIA, Feb. 21, 2014 /PRNewswire-USNewswire/ -- An antibody found in the blood of people with multiple sclerosis (MS) may be present long before the onset of the disease and its symptoms, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014. "If our results can be replicated in larger populations, our findings may help to detect MS earlier in a subgroup of patients," said...

2013-12-19 10:35:03

A newly identified immune protein influences each person's response to vaccines and risk for autoimmune diseases like lupus and multiple sclerosis, according to a study published today by researchers from the School of Medicine at the University of Alabama at Birmingham in the journal Science Translational Medicine. The protein, called a receptor and part of signaling pathways, also provides a new target for personalized therapies for patients with autoimmune diseases. The research team...

2013-11-04 04:21:59

BREDA, The Netherlands and GHENT, Belgium, November 4, 2013 /PRNewswire/ -- Funds to advance ARGX-113, a novel antibody fragment approach to promote degradation and clearance of disease-causing autoantibodies, towards clinical development arGEN-X, a clinical stage human therapeutic antibody company, has raised EUR 5 million ($6.8 million) as an extension of its series B financing round from the Flemish investment company PMV as a new investor. arGEN-X' series B round,...

2013-10-28 00:22:31

Hasselt University and INOVA Diagnostics Enter into a Research Collaboration and License Agreement for Novel Diagnostics HASSELT, Belgium and SAN DIEGO, Oct. 28, 2013 /PRNewswire/ -- Hasselt University and INOVA Diagnostics are pleased to announce the completion of an exclusive, worldwide license agreement and research collaboration for technology developed at the University. This technology represents an important advance in the diagnosis of Rheumatoid Arthritis (RA). VIB, the...

2013-10-25 16:23:58

VANCOUVER, Oct. 25, 2013 /PRNewswire/ - Augurex Life Sciences Corp. announced today the expansion of key data related to its innovative 14-3-3eta biomarkers with scheduled presentations next week at the prestigious American College of Rheumatology Annual Meeting, taking place at the San Diego Convention Center, October 25-30, 2013. World-leading investigators will present data, including a late-breaking study, describing 14-3-3eta's clinical utility for rheumatoid arthritis (RA)...

2013-10-09 12:26:41

2013 Distinguished Innovators Awards Support Large-scale Novel Studies to Find Root Causes that Can Drive to a Cure NEW YORK, Oct. 9, 2013 /PRNewswire/ -- The Lupus Research Institute (LRI) announced recipients of its 2013 Distinguished Innovator Award, taking the organization across the globe to support highly innovative studies on two continents. Now the world's largest private grants in novel lupus research, the LRI Distinguished Innovator Award supports large-scale studies for...

2013-09-12 04:22:30

BREDA, the Netherlands and GHENT, Belgium, September 12, 2013 /PRNewswire/ -- - Breakthrough data to be presented during the 'Discovery on Target' conference in Boston, MA, USA on September 23, 2013 arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody(TM) technology. Nav1.7 has been thoroughly validated...

2013-08-15 08:28:23

--Genalyte Launches Multiplexed Biomarker Panel that Measures Seven Autoantigens Associated with the Development of Type 1 Diabetes-- SAN DIEGO, Aug. 15, 2013 /PRNewswire/ -- Genalyte, Inc. today announced the launch of its Type 1 Diabetes (T1D) antigen panel that runs on the Maverick(TM )Detection System. The Genalyte T1D antigen panel is the first multiplexed assay that measures seven autoantibodies associated with the destruction of pancreatic islet cells seen in type 1...

2013-07-09 12:28:05

Pediatric Biosciences Developing Diagnostic Test Based on Findings SAN DIEGO, July 9, 2013 /PRNewswire/ -- Pediatric Biosciences, Inc. (PBI) today announced the publication of a new study showing that a significant percentage of women who have children diagnosed with autism have highly specific autoantibodies in their blood. These autoantibodies target and interfere with fetal brain proteins that play a major role in their child's neurodevelopment in utero. The finding pinpoints a...

2013-06-19 14:04:28

The majority of children at risk of type 1 diabetes who developed 2 or more diabetes-related autoantibodies developed type 1 diabetes within 15 years, findings that highlight the need for research into finding interventions to stop the development of multiple islet autoantibodies, according to a study in the June 19 issue of JAMA. "Type 1 diabetes is a chronic autoimmune disease that often manifests during childhood and adolescence. The lifelong requirement for insulin injections and the...